New HIV vaccine shows unprecedented success in preclinical study
LA JOLLA, CA—A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists, and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV vaccine is the first to generate a high number of “broadly neutralizing,” virus-fighting antibodies in primates.
LA JOLLA, CA—A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists, and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV vaccine is the first to generate a high number of “broadly neutralizing,” virus-fighting antibodies in primates.
Source: lji.org (486 points, 220 comments) Hacker News discussion
Reader Support
Support WebNovare
Send a crypto tip if this article helped you.
Log in or register to like, bookmark, watch tags, and comment.
Comments
No comments yet.
Log in or register to join the conversation.